Literature DB >> 19047995

Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition.

Giovanna Sarno1, Amir Lerman, Jang-Ho Bae, Christoph Schukro, Dietmar Glogar, Pauliina M Margolis, Marc Goethals, Sofie Verstreken, Jozef Bartunek, Andreas Koenig, William Wijns, Marc Vanderheyden.   

Abstract

BACKGROUND: Coronary allograft vasculopathy is a severe complication of heart transplantation. We used virtual histology intravascular ultrasound to characterize plaque burden and tissue composition over time in heart transplant recipients.
METHODS: We recruited patients undergoing heart transplantation in four centers in Europe and the US between 2004 and 2006. We used intravascular ultrasound to obtain morphological plaque measurements and to perform virtual histology in the left anterior descending coronary artery. Data were characterized according to the duration between transplantation and intravascular ultrasound assessment: <or=24, >24-60, >60-120 and >120-192 months.
RESULTS: We assessed vessels from 152 patients (mean age 58 +/- 12 years) a mean of 70 +/- 53 months (range 1 week to 16 years) after transplantation. Plaque burden of >40% was observed in 26% of vessels analyzed, with increases from baseline being seen in all time categories. If assessed >24 months after transplantation, necrotic core and dense calcified volumes were significantly greater than at baseline (P = 0.0005 and P = 0.01, respectively). Time since heart transplantation and donor age and recipient age were independent predictive factors of increased necrotic core content. Necrotic core volume >2.01 mm(3), diabetes mellitus, donor age older than 40 years, follow-up from transplantation longer than 5 years and recipient age older than 58 years were associated with the need for revascularization.
CONCLUSIONS: In coronary allograft vasculopathy, plaque burden and composition change over time and seem to affect clinical outcome. This relationship might facilitate identification of high-risk patients in whom the value of more aggressive medical therapy should be tested.

Entities:  

Mesh:

Year:  2008        PMID: 19047995     DOI: 10.1038/ncpcardio1410

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  39 in total

Review 1.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Coronary plaque classification with intravascular ultrasound radiofrequency data analysis.

Authors:  Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

3.  The registry of the international society for heart and lung transplantation: nineteenth official report-2002.

Authors:  Marshall I Hertz; David O Taylor; Elbert P Trulock; Mark M Boucek; Paul J Mohacsi; Leah B Edwards; Berkeley M Keck
Journal:  J Heart Lung Transplant       Date:  2002-09       Impact factor: 10.247

4.  Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005.

Authors:  David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Mario C Deng; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

5.  Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.

Authors:  E Esper; S Glagov; R B Karp; K K Simonsen; S R Filer; A M Scanu; M E Sand
Journal:  J Heart Lung Transplant       Date:  1997-04       Impact factor: 10.247

6.  Systemic inflammatory response in cardiac allograft vasculopathy: high-sensitive C-reactive protein is associated with progressive luminal obstruction.

Authors:  K Pethig; B Heublein; I Kutschka; A Haverich
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

7.  Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

Authors:  B F Uretsky; S Murali; P S Reddy; B Rabin; A Lee; B P Griffith; R L Hardesty; A Trento; H T Bahnson
Journal:  Circulation       Date:  1987-10       Impact factor: 29.690

8.  Metabolic risk factors for atherosclerosis in heart transplant recipients.

Authors:  M S Kemna; H A Valantine; S A Hunt; J S Schroeder; Y D Chen; G M Reaven
Journal:  Am Heart J       Date:  1994-07       Impact factor: 4.749

9.  Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.

Authors:  E M Tuzcu; A C De Franco; M Goormastic; R E Hobbs; G Rincon; C Bott-Silverman; P McCarthy; R Stewart; E Mayer; S E Nissen
Journal:  J Am Coll Cardiol       Date:  1996-03-15       Impact factor: 24.094

10.  The spectrum of coronary artery pathologic findings in human cardiac allografts.

Authors:  D E Johnson; S Z Gao; J S Schroeder; W M DeCampli; M E Billingham
Journal:  J Heart Transplant       Date:  1989 Sep-Oct
View more
  5 in total

1.  C-reactive protein and severity of coronary allograft vasculopathy.

Authors:  Carlos A Labarrere; John R Woods; Miguel A Ortiz; Gonzalo L Campana
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

2.  Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation.

Authors:  Yoshiki Matsuo; Andrew Cassar; Satoshi Yoshino; Andreas J Flammer; Jing Li; Rajiv Gulati; Yan Topilsky; Eugenia Raichlin; Ryan J Lennon; Lilach O Lerman; Charanjit S Rihal; Sudhir S Kushwaha; Amir Lerman
Journal:  J Heart Lung Transplant       Date:  2013-08       Impact factor: 10.247

3.  Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.

Authors:  Marcus Franz; K Grün; P Richter; B R Brehm; M Fritzenwanger; K Hekmat; D Neri; J Gummert; H R Figulla; H Kosmehl; A Berndt; A Renner
Journal:  Histochem Cell Biol       Date:  2010-10-08       Impact factor: 4.304

4.  Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Authors:  Kozo Okada; William F Fearon; Helen Luikart; Hideki Kitahara; Kyuhachi Otagiri; Shigemitsu Tanaka; Takumi Kimura; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; Hannah A Valantine; Kiran K Khush; Yasuhiro Honda
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

5.  Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography.

Authors:  Madeleine Orban; Dominic Dischl; Christoph Müller; Sarah Ulrich; Tobias Petzold; Konstantinos Rizas; Martin W Orban; Daniel Braun; Jörg Hausleiter; Christian Hagl; Julinda Mehilli; Steffen Massberg
Journal:  Transplant Direct       Date:  2021-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.